Founded in 2021, Power Life Sciences provides a platform, Power, that helps patients and researchers participate in clinical trials. The Power platform helps users sort through listed clinical trials according to area of treatment, geography, age restrictions, and distance from trial participants. The platform additionally provides plain-language summaries of listed clinical trials to help reduce medical jargon and give participants the confidence to find the best clinical trial for their condition. Additionally, participants can contact trial researchers directly to request additional details on listed trials.
Key customers and partnerships
As of February 2024, the company noted that within the last year, it has served over 600,000 patients seeking clinical trials and has experienced a 20% monthly increase in study team participation, leading to enhanced efficiency and quickened enrolment.
Funding and financials
In February 2024, Power Life Sciences secured USD 11.9 million in a Series A financing round co-led by Kin Ventures, Contrary, and Footwork. The company intended to use the raised funds to expand its platform, support researchers, and create a more equitable clinical trial ecosystem.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.